Literature DB >> 8624803

Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor.

J J Ryan1, L J McReynolds, A Keegan, L H Wang, E Garfein, P Rothman, K Nelms, W E Paul.   

Abstract

IL-4 causes hematopoietic cells to proliferate and express a series of genes, including CD23. We examined whether IL-4-mediated growth, as measured by 4PS phosphorylation, and gene induction were similarly controlled. Studies of M12.4.1 cells expressing human IL-4R truncation mutants indicated that the region between amino acids 557-657 is necessary for full gene expression, which correlated with Stat6 DNA binding activity. This region was not required for 4PS phosphorylation. Tyrosine-to-phenylalanine mutations in the interval between amino acids 557-657 revealed that as long as one tyrosine remained unmutated, CD23 was fully induced. When all three tyrosines were mutated, the receptor was unable to induce CD23. The results indicate that growth regulation and gene expression are principally controlled by distinct regions of IL-4R.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8624803     DOI: 10.1016/s1074-7613(00)80677-9

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  29 in total

Review 1.  Molecular mechanisms in T helper phenotype development.

Authors:  J D Farrar; S H Ranganath; K M Murphy
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  IL-4 signaling, gene transcription regulation, and the control of effector T cells.

Authors:  M Boothby; A L Mora; M A Aronica; J Youn; J R Sheller; S Goenka; L Stephenson
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

3.  Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway.

Authors:  M C Rouyez; C Boucheron; S Gisselbrecht; I Dusanter-Fourt; F Porteu
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

Review 4.  Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma.

Authors:  Douglas A Kuperman; Robert P Schleimer
Journal:  Curr Mol Med       Date:  2008-08       Impact factor: 2.222

5.  Effects of common atopy-associated amino acid substitutions in the IL-4 receptor alpha chain on IL-4 induced phenotypes.

Authors:  Izolda Franjkovic; Andre Gessner; Inke König; Karin Kissel; Anette Bohnert; Anne Hartung; Astrid Ohly; Andreas Ziegler; Holger Hackstein; Gregor Bein
Journal:  Immunogenetics       Date:  2005-01-27       Impact factor: 2.846

6.  Activation of the STAT6 transcription factor in Jurkat T-cells by the herpesvirus saimiri Tip protein.

Authors:  Yuri Kim; Eun-Kyung Kwon; Ju-Hong Jeon; Insuk So; In-Gyu Kim; Myung-Sik Choi; Ik-Sang Kim; Joong-Kook Choi; Jae Ung Jung; Nam-Hyuk Cho
Journal:  J Gen Virol       Date:  2011-10-19       Impact factor: 3.891

7.  Comparison of the transactivation domains of Stat5 and Stat6 in lymphoid cells and mammary epithelial cells.

Authors:  R Moriggl; S Berchtold; K Friedrich; G J Standke; W Kammer; M Heim; M Wissler; E Stöcklin; F Gouilleux; B Groner
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

Review 8.  Role of anti-inflammatory cytokines IL-4 and IL-13 in systemic sclerosis.

Authors:  Xiao-Lei Huang; Yu-Jie Wang; Jun-Wei Yan; Ya-Nan Wan; Bing Chen; Bao-Zhu Li; Guo-Jun Yang; Jing Wang
Journal:  Inflamm Res       Date:  2015-03-01       Impact factor: 4.575

Review 9.  History of interleukin-4.

Authors:  William E Paul
Journal:  Cytokine       Date:  2015-03-23       Impact factor: 3.861

10.  NF-κB signaling participates in both RANKL- and IL-4-induced macrophage fusion: receptor cross-talk leads to alterations in NF-κB pathways.

Authors:  Minjun Yu; Xiulan Qi; Jose L Moreno; Donna L Farber; Achsah D Keegan
Journal:  J Immunol       Date:  2011-07-06       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.